How Do Urologists Tell Enlarged Prostate, Prostatitis and Prostate Cancer Apart?

A man in his late fifties sits in an exam room turning his phone over in his hands. For months he has been getting up twice a night to urinate. Last week a friend the same age was told he had prostate cancer. Now every trip to the bathroom feels like a question he cannot answer on his own.

His situation is common, and so is the confusion behind it. The three main types of prostate disease share one small gland and, at first glance, a similar set of complaints. Yet they are very different problems with very different outlooks. One is a normal part of aging that happens to be inconvenient. One is inflammation or infection. One is a cancer that, in its early stages, is usually silent.

What follows is how a urologist actually pulls those three apart, step by step, and why the process is more methodical, and less alarming, than most people imagine.

What are the three main types of prostate disease?

Almost every prostate complaint a urologist sees falls into one of three categories, and the names matter because they describe what is physically happening to the gland.

Benign prostatic hyperplasia, usually shortened to BPH, means the prostate has grown larger through the multiplication of normal, non-cancerous cells. It is by far the most common of the three. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) notes that BPH affects about half of men between 51 and 60 and up to 90 percent of men older than 80. The word benign is doing real work here: BPH does not turn into cancer.

Prostatitis means inflammation of the prostate. Sometimes bacteria are the cause, and sometimes no infection can be found at all. Unlike the other two conditions, it is not tied to aging and can appear in men in their twenties and thirties.

Prostate cancer means that cells in the gland have begun to grow in an uncontrolled way and may, over time, spread beyond it. According to the Centers for Disease Control and Prevention, it is the most common cancer in American men after skin cancer, and most cases are found in men over 65.

The three can overlap. A man can have an enlarged prostate and, quite separately, a small cancer. Inflammation can raise a blood test that is also raised in cancer. That overlap is exactly why the diagnostic process exists. A urologist is not asking “which one of these do you have?” so much as “which of these explains what I am seeing, and have I ruled out the one that matters most?”

Keeping the three distinct in your own mind is the first step toward a calmer, more useful conversation with your care team.

Where is the prostate and why does it cause urinary trouble?

The prostate sits just below the bladder, in front of the rectum, wrapped around the urethra like a ring around a straw. The urethra is the tube that carries urine and semen out of the body. That arrangement is the root of nearly every prostate symptom: anything that swells the gland, whether growth, inflammation or a tumor, squeezes the tube running through its middle.

In young adulthood the prostate is about the size of a walnut, according to the NIDDK. Its job is to produce part of the fluid in semen and to help push that fluid forward during ejaculation. It also makes a protein called prostate-specific antigen, or PSA, which thins semen and which leaks into the bloodstream in small amounts. PSA becomes important later in this story.

Because the rectum lies directly behind the prostate, a clinician can feel the back surface of the gland with a gloved finger. This is the digital rectal exam, and it remains a routine part of assessment because it gives information no blood test can: the size, the firmness, whether the two lobes feel symmetrical, and whether there are hard nodules.

The gland is also divided into zones. Most benign enlargement happens in the transition zone, the tissue closest to the urethra, which explains why BPH so reliably produces a weak stream and a sense of incomplete emptying. Most cancers, by contrast, begin in the peripheral zone at the back and outer edge of the gland. A tumor can grow there for years without touching the urethra, which is why early prostate cancer so often produces no urinary symptoms at all. Anatomy, in other words, already explains half of what a urologist is looking for.

What happens in an enlarged prostate (BPH)?

The prostate goes through two growth spurts. The first arrives at puberty. The second begins around age 25 and, according to the NIDDK, continues through most of a man’s life. Nobody fully understands why, though changing hormone levels with age, including the balance between testosterone and its more active form dihydrotestosterone, are thought to drive it.

As the transition zone thickens, two things happen. The urethra narrows, and the smooth muscle within the prostate and at the bladder neck tightens. The bladder responds by working harder, and over time its wall can become thick and irritable. That is why BPH produces a double set of complaints: obstructive ones, such as a weak or interrupted stream, straining, and dribbling at the end, and storage ones, such as urgency, frequency and waking at night to urinate.

Symptoms typically build over years, not weeks. The Mayo Clinic notes that the size of the prostate does not always match the severity of symptoms; some men with very large glands have little trouble, while others with modest enlargement are bothered constantly. What matters clinically is the degree of blockage and how the bladder is coping.

Left unmanaged, significant obstruction can occasionally lead to complications: urinary retention, in which the bladder cannot empty at all, repeated urinary infections, bladder stones, or, rarely, strain on the kidneys. These outcomes are uncommon and are precisely what regular follow-up aims to prevent.

Two facts about BPH deserve underlining. It is not a precursor to cancer, and having BPH does not change a man’s risk of developing prostate cancer, according to the NHS. It is, in the most literal sense, a plumbing problem.

What causes prostatitis, and which type is most common?

Prostatitis is the odd one out. It is the only one of the three types of prostate disease that commonly affects younger men, and the only one where pain, rather than urinary change, is often the leading complaint.

Clinicians divide it into four categories. Acute bacterial prostatitis is a sudden infection, usually caused by bacteria that travel up from the urinary tract. It tends to arrive with fever, chills, deep pelvic or lower back pain and painful, difficult urination, and it can make a person feel genuinely ill. It is the least common form but the most urgent.

Chronic bacterial prostatitis is a lingering or recurring infection, often producing repeated urinary tract infections with quieter symptoms in between.

Chronic prostatitis, also called chronic pelvic pain syndrome, is the most common type, according to the NIDDK. Here no infection can be found, yet pain in the pelvis, perineum, testicles or lower back persists for months. Its causes are not fully understood; nerve sensitivity, pelvic floor muscle tension, past infection and stress have all been proposed.

Asymptomatic inflammatory prostatitis is inflammation discovered incidentally, for example in a biopsy, in someone who has no symptoms and needs no treatment.

So the honest answer to “what is the most common cause of prostatitis?” is that in the majority of cases, no single cause is identified. When bacteria are responsible, the culprits are typically the same gut organisms that cause bladder infections, which is why a urine culture is one of the first tests ordered.

Prostatitis can raise PSA sharply, sometimes to levels that would otherwise prompt concern about cancer. Recognizing this prevents unnecessary biopsies, which is one reason a urologist asks about recent infections before interpreting any blood result.

Enlarged prostate vs prostate cancer: why the symptoms overlap and where they differ

This is the comparison that keeps men awake, so it is worth being direct. The symptoms of an enlarged prostate and the symptoms of advanced prostate cancer can look identical, because both eventually press on the urethra. The crucial difference is timing and location: BPH squeezes the urethra early because it grows next to it, while cancer usually begins at the outer edge of the gland and reaches the urethra late, if ever.

The practical consequence, stated plainly by the NHS and the Mayo Clinic, is that early prostate cancer usually causes no symptoms. Men who are diagnosed early are almost always found through a PSA test or an exam, not because something felt wrong. Conversely, a man with pronounced urinary symptoms most often has BPH, not cancer.

When cancer does produce symptoms, a few features raise a clinician’s attention more than others. Blood in the urine or semen, difficulty getting an erection that is new, unexplained weight loss, or persistent pain in the hips, back or pelvis can all point toward a process that has moved beyond the gland. None of these is specific to cancer; infection, stones and ordinary aging cause most of them. They are prompts for evaluation, not a verdict.

On examination, the two conditions can feel different. BPH tends to produce a smoothly enlarged, rubbery gland. Cancer may produce a hard, irregular nodule or an area of asymmetry. An experienced examiner learns a great deal from this, though the exam misses tumors on the front of the gland and small tumors anywhere, which is why it is never used alone.

The takeaway for the man in the waiting room: bothersome urination is a reason to be seen, not a reason to assume the worst. Silence from the prostate is not reassurance either. Only testing settles the question.

What does a urologist actually do at the first appointment?

The visit is more conversation than procedure. A urologist will begin with the history, because the pattern of symptoms narrows the possibilities fast. How long has this been going on? Weeks suggest infection or inflammation; years suggest gradual enlargement. Is there pain, fever or a burning sensation? Those lean toward prostatitis. Have there been urinary infections before, or a catheter, or recent sexual health concerns? Is there a family history of prostate cancer, particularly in a father or brother, which the CDC identifies as a factor that raises risk?

Many clinics use a standardized questionnaire, the International Prostate Symptom Score, which asks about seven urinary symptoms and how much they interfere with daily life. It is not a diagnostic test. It is a way of measuring how bothered someone is, so that changes over time can be tracked rather than guessed.

The physical exam follows. The abdomen is checked for a full bladder, and the digital rectal exam assesses the gland itself. The exam takes under a minute and is uncomfortable rather than painful for most people.

Initial tests are simple. A urine sample is checked for blood, infection and, in some cases, sent for culture. A PSA blood test is usually drawn, ideally when there is no active infection, since inflammation distorts the result. Some urologists measure the urine flow rate with a device that records how quickly the stream comes out, and use a small ultrasound probe on the abdomen to estimate how much urine remains in the bladder after voiding.

By the end of the first visit, the urologist usually has a working picture. Most men leave with a probable diagnosis of BPH or prostatitis and a plan. A smaller group leaves with a plan for further testing, which is a step in a process, not a diagnosis.

How are PSA test results interpreted, and why is one number never enough?

PSA is the test that causes the most anxiety and is the most misunderstood. It is a protein made by normal prostate cells, not by cancer specifically. Anything that disturbs the gland releases more of it into the blood: benign enlargement, infection, inflammation, recent ejaculation, vigorous cycling, and yes, cancer.

That is why a raised PSA is a signal to look further, not a diagnosis. The NHS states that around 3 in 4 men with a raised PSA level do not have prostate cancer. At the same time, some men with cancer have a PSA in the expected range. The test has real value and real limits, and a good urologist explains both.

Interpretation therefore depends on context. A urologist considers age, since PSA rises naturally as the gland grows; prostate size, since a large benign gland produces more PSA; and recent events, since a urinary infection can push the number up for weeks. If infection is suspected, the sensible move is often to treat it and repeat the test, rather than rushing to biopsy a temporarily inflamed gland.

The trend matters as much as the value. A PSA that climbs steadily over repeated tests is more concerning than a single high reading that settles. Some clinicians also calculate PSA density, dividing the PSA by the gland’s volume measured on ultrasound or MRI, because a modest PSA in a small gland is more suspicious than the same number in a very large one.

Newer refinements include the ratio of free to total PSA and other blood or urine markers. None replaces judgment. When a man asks “is my PSA bad?”, the accurate answer is usually “it depends on everything else we know about you,” which is frustrating to hear and entirely true.

Types of prostate disease at a glance: a comparison table

Seeing the three conditions side by side makes the urologist’s reasoning easier to follow. The table summarizes typical patterns as described by the NIDDK, the NHS and the Mayo Clinic. Individual cases vary, and overlap is common, so treat this as a map rather than a rulebook.

Feature	Enlarged prostate (BPH)	Prostatitis	Prostate cancer
What is happening	Non-cancerous growth of the inner gland	Inflammation, with or without infection	Uncontrolled growth of abnormal cells
Typical age	Mostly over 50; increases with age	Any age; common in younger and middle-aged men	Mostly over 50; most cases over 65
Onset	Gradual, over years	Sudden (acute) or persistent (chronic)	Usually silent early; symptoms appear late
Leading complaint	Weak stream, frequency, nighttime urination	Pelvic pain, burning, sometimes fever	Often none; later, blood in urine, bone pain
Feel on exam	Smooth, enlarged, rubbery	Tender, sometimes warm or boggy	Hard nodule or asymmetry, or normal
PSA	Mildly raised in proportion to size	Can rise sharply, then fall after treatment	Often raised, but can be normal
Key tests	Symptom score, flow rate, ultrasound	Urine tests and culture	PSA trend, MRI, biopsy
Risk to life	Low; complications are uncommon	Low, except untreated acute infection	Varies widely with grade and stage

Two rows deserve a second look. The PSA row shows why a single blood value cannot separate the conditions on its own. The onset row shows why a urologist places so much weight on the history: the same symptom arriving over three days means something different from the same symptom arriving over three years.

When is a prostate biopsy needed, and who is usually asked to wait?

A biopsy, the removal of tiny cores of prostate tissue for examination under a microscope, is the only way to confirm prostate cancer. It is also the step most men dread, so it helps to know how urologists decide who needs one.

Biopsy is usually considered when PSA is persistently raised without a benign explanation, when the rectal exam finds a suspicious area, or when both occur together. Increasingly, an MRI scan of the prostate is performed first. The NHS now uses MRI before biopsy in its standard pathway, because the scan can show whether there is an area worth sampling and, in many cases, can support a decision not to biopsy at all. When a biopsy is performed, the MRI images are often used to guide the needles to the suspicious region.

Who is usually asked to wait? Men whose raised PSA coincides with a urinary infection are typically treated and retested first. Men with a modest PSA, a normal exam and an MRI showing no suspicious area are often monitored with repeat blood tests rather than biopsied. Men whose general health means that a cancer diagnosis would not change their care may, after discussion, choose not to pursue testing at all. These are judgment calls, and the treating team makes them together with the patient.

The procedure itself is done through the rectum or through the skin of the perineum, under local or general anesthesia, and usually takes 10 to 20 minutes, according to the NHS. Common after-effects include blood in the urine or semen for a few weeks and some soreness. Infection is the main serious risk, which is one reason perineal approaches are being used more often.

If cancer is found, the pathologist assigns a grade, most often expressed as a Gleason score or Grade Group, describing how abnormal the cells look. That grade, more than the PSA, shapes what happens next.

What do the following days and weeks usually look like after a diagnosis?

The pace of what follows depends entirely on which diagnosis emerges, and knowing the typical timeline removes a good deal of dread.

For BPH, the weeks after diagnosis are unhurried. Many men begin with lifestyle adjustments and, if symptoms warrant, a medicine. Alpha blockers, which relax muscle in the prostate and bladder neck, tend to improve flow within days to a few weeks. Medicines that shrink the gland by blocking dihydrotestosterone work slowly; the NHS notes it can take up to six months to see the full effect. A follow-up visit to review symptoms and side effects is typical within a few months. Whether to continue, adjust or consider a procedure is a decision for the prescribing clinician.

For acute bacterial prostatitis, the timeline is measured in days. Antibiotics are started promptly, sometimes in hospital if the person is very unwell or cannot pass urine. The NHS describes courses of 2 to 4 weeks for acute infection and longer courses, often 4 to 12 weeks, for chronic bacterial prostatitis. Symptoms usually ease within the first days, but completing the course as prescribed matters. Chronic pelvic pain syndrome follows a longer, less linear path, often involving pelvic floor physical therapy, pain strategies and periodic review.

For prostate cancer, the first weeks are about staging: working out whether the cancer is confined to the gland. Depending on grade and PSA, this may involve a bone scan, a CT scan or a specialized PET scan. Results are typically discussed in a multidisciplinary meeting, where urologists, oncologists and radiologists agree on options before meeting the patient. Low-grade cancers are often placed on active surveillance, meaning regular PSA tests, exams and MRI rather than immediate treatment. Higher-grade disease prompts a conversation about surgery, radiotherapy or hormone therapy.

In all three cases, the plan is revisited rather than fixed. Follow-up is a feature of good care, not a sign that something has gone wrong.

How is each type of prostate disease usually managed, and what is the latest treatment for an enlarged prostate?

Management follows the mechanism. Because BPH is a mechanical problem, treatments either relax the muscle around the urethra, shrink the tissue, or physically widen the channel.

Medicines come first for most men. Alpha blockers act on smooth muscle to reduce squeeze. 5-alpha reductase inhibitors lower dihydrotestosterone so the gland gradually shrinks. A third class, originally developed for erectile dysfunction, is sometimes used for urinary symptoms as well. Each has recognized side effects, from dizziness to changes in ejaculation and sexual function, which the prescribing clinician weighs against the benefit.

Procedures are considered when medicines are not enough or not tolerated. The long-standing standard is transurethral resection of the prostate, or TURP, in which tissue is shaved away from inside the urethra. Laser techniques remove or vaporize tissue with less bleeding. Newer, less invasive options include prostatic urethral lift, which uses small implants to hold the lobes apart; water vapor thermal therapy, which uses steam to shrink tissue; and robotic waterjet ablation. When people ask about “the latest treatment,” these are usually what they mean. The Mayo Clinic describes them as options that may suit some men, particularly those wishing to preserve ejaculatory function, while noting that longer-term evidence is still accumulating compared with TURP. Which is appropriate depends on gland size, anatomy and personal priorities, and is a decision for the treating urologist.

Prostatitis is managed according to type: antibiotics for bacterial forms, and for chronic pelvic pain syndrome a combination of pelvic floor therapy, anti-inflammatory strategies, alpha blockers in some cases, and attention to stress and bowel habits.

Prostate cancer management ranges from watchful waiting and active surveillance through surgery to remove the gland, external or internal radiotherapy, hormone therapy that lowers testosterone, and, for advanced disease, chemotherapy or targeted agents. Each carries its own trade-offs for urinary control and sexual function, and the choice is made with the whole team.

Does prostate size by age matter, and what three daily habits actually help?

Men often ask for a normal prostate size at their age, hoping for a number that settles things. There is no clean chart. The NIDDK describes a walnut-sized gland in young adulthood that keeps enlarging from roughly age 25 onward, so a somewhat larger prostate in a man of 60 is expected, not alarming. Urologists measure volume by ultrasound or MRI mainly to choose treatment and to interpret PSA, not to declare a gland normal or abnormal. Size predicts symptoms poorly; the bladder’s response and the shape of the enlargement matter more.

What about prevention? The honest answer is that no habit is proven to prevent BPH or prostatitis, and evidence on preventing prostate cancer is mixed. Still, three practical habits have reasonable support for reducing symptoms and supporting overall health.

First, manage fluids intelligently rather than restricting them. The NHS suggests reducing caffeine and alcohol, both of which irritate the bladder, and limiting drinks in the two hours before bed to ease nighttime urination. Dehydration during the day, by contrast, concentrates urine and worsens irritation.

Second, stay physically active and keep weight in a healthy range. The Mayo Clinic notes that obesity is associated with more bothersome BPH symptoms and with higher-risk prostate cancer. Regular activity also helps the constipation that can aggravate pelvic pain.

Third, eat a plant-forward diet. On the widely searched question of dairy and calcium, the NIH Office of Dietary Supplements summarizes the evidence as inconsistent: some studies link very high calcium or dairy intake to greater prostate cancer risk, others find no association, and no guideline advises men to avoid dairy on that basis. Moderation rather than elimination is the defensible position.

None of these habits replaces testing. They are things a man can control while his care team handles the rest.

What people often get wrong about prostate problems

Myths around the prostate are stubborn, partly because the gland is private and partly because the conditions overlap. A few corrections, each grounded in mainstream guidance.

“An enlarged prostate leads to cancer.” It does not. BPH and prostate cancer arise in different zones of the gland through different processes. The NHS is explicit that having BPH does not increase cancer risk. A man can have both, but one does not cause the other.

“No symptoms means no cancer.” The reverse is closer to the truth. Early prostate cancer is typically silent, according to the Mayo Clinic and the NHS, which is why it is usually found by testing. Waiting for symptoms is waiting for a later stage.

“A high PSA means cancer.” Around three in four men with a raised PSA do not have prostate cancer, per the NHS. Infection, enlargement and even a long bike ride can raise it.

“Prostatitis is a sexually transmitted infection.” Most prostatitis is not infectious at all, and when bacteria are involved they are usually gut organisms from the urinary tract, not sexually transmitted ones, according to the NIDDK.

“Frequent ejaculation prevents or causes prostate disease.” Studies have explored links between ejaculation frequency and cancer risk, but the evidence is observational and inconsistent, and no guideline makes a recommendation either way.

“Supplements shrink the prostate.” Saw palmetto is the most popular, and the NIH Office of Dietary Supplements reports that well-designed trials have not shown it to improve urinary symptoms better than placebo. It is generally well tolerated, but it should not delay proper evaluation.

“Prostate cancer is always slow, so it can be ignored.” Many prostate cancers are slow-growing, which is why active surveillance exists, but some are aggressive. Grade, not reputation, determines urgency.

Questions to ask your care team

A urology appointment moves quickly, and the questions men wish they had asked usually surface in the parking lot. Writing a few down in advance changes the quality of the visit. The most useful questions are the ones that clarify which of the three conditions is suspected and what the next step is meant to establish.

• Based on what you have found today, which of the three types of prostate disease do you think is most likely, and which have you ruled out?
• What does my PSA mean in the context of my age and prostate size, and should it be repeated before any further testing?
• Could a recent infection or anything else have affected my results?
• If you are recommending an MRI or biopsy, what specifically are you looking for, and what would each possible result lead to?
• If this is BPH, how are my symptoms affecting my bladder, and is there any sign of retention or kidney strain?
• If this is prostatitis, which type do you suspect, and how long would you expect treatment to take before we reassess?
• If cancer is found, would active surveillance be an option for me, and how would we monitor it?
• What side effects should I expect from the medicine or procedure you are suggesting, and how would we know it is working?
• Who do I contact between appointments if something changes, and what changes should prompt a call?

It also helps to bring a list of current medicines, including over-the-counter products and supplements, since some can affect urination or interact with prostate treatments. If a partner or family member can attend, a second set of ears often catches details that anxiety filters out. There are no naive questions here; the conditions are genuinely confusing, and clinicians expect to explain them more than once.

When to call your doctor

Most prostate symptoms are slow-moving and can wait for a scheduled appointment. A few cannot, and recognizing them matters more than remembering every detail above.

Seek urgent care the same day if you suddenly cannot pass urine at all, especially with a painful, swollen lower abdomen. This is acute urinary retention, and the bladder needs to be drained promptly, usually with a catheter. Seek urgent care as well for fever, chills or shaking alongside pelvic pain or difficulty urinating, which can signal acute bacterial prostatitis or a kidney infection that may need treatment in hospital.

Contact your doctor within a day or two if you notice blood in your urine or semen, since it needs an explanation even when the cause turns out to be benign. Do the same for new, persistent pain in the lower back, hips or pelvis that is not obviously musculoskeletal, for unexplained weight loss, or for urinary symptoms that have worsened noticeably over a few weeks rather than years.

Men already being treated should call if a new medicine causes fainting or severe dizziness, if symptoms return after a course of antibiotics, or if a scheduled PSA result comes back higher than expected and no one has discussed it with them.

Men on active surveillance for prostate cancer should never let a monitoring appointment lapse without rescheduling; the strategy depends on regular checks.

Finally, if something about your body has changed and you cannot explain it, that alone justifies a call. Urologists would far rather see a man early with a benign problem than late with a serious one. The decision about what your symptoms mean, and what to do about them, belongs with your treating team. Your job is simply to make sure they hear about it.

Frequently asked questions

What is the most common cause of prostatitis?

In most cases no infection is found; the most common type is chronic prostatitis, also called chronic pelvic pain syndrome, according to the NIDDK. When bacteria are responsible, they are usually the same gut organisms that cause urinary tract infections, which travel up the urethra into the gland. Pelvic floor muscle tension, nerve sensitivity and previous infection are thought to contribute to the non-bacterial form.

Enlarged prostate vs prostate cancer: can a doctor tell the difference by symptoms alone?

No. Symptoms overlap because both conditions can compress the urethra, and early prostate cancer usually causes no symptoms at all. A urologist relies on the exam, PSA trend, urine tests and often MRI to separate them. Pronounced urinary symptoms most often point to benign enlargement, while a hard nodule on exam or a persistently rising PSA raises concern for cancer and prompts further testing.

What is the typical prostate size range for different ages?

There is no precise chart. The NIDDK describes a walnut-sized gland in young adulthood that begins a second growth phase around age 25 and keeps enlarging through most of life, so a larger prostate in a man over 60 is expected. Urologists measure volume mainly to interpret PSA and plan treatment, because size alone predicts symptoms poorly.

What are three daily habits that can help protect the prostate?

Manage fluids sensibly by reducing caffeine and alcohol and limiting drinks two hours before bed, stay physically active and maintain a healthy weight, and eat a plant-forward diet with dairy in moderation. None of these is proven to prevent prostate disease, but the NHS and Mayo Clinic describe them as reasonable ways to ease urinary symptoms and support overall health while your care team handles testing.

What is the latest treatment for an enlarged prostate?

Newer minimally invasive procedures include prostatic urethral lift, water vapor thermal therapy and robotic waterjet ablation, alongside established laser techniques and TURP. The Mayo Clinic notes these may suit some men, particularly those wishing to preserve ejaculation, though long-term evidence is still accumulating compared with TURP. Suitability depends on gland size, anatomy and priorities, and the choice rests with the treating urologist.

How are PSA test results interpreted if I have both an enlarged prostate and a raised level?

A urologist considers your age, gland volume and recent events such as infection, because a large benign prostate naturally produces more PSA. Many calculate PSA density, dividing the value by prostate volume, since a modest PSA in a very large gland is less concerning than the same number in a small one. A repeat test and, if needed, an MRI usually follow before any biopsy is considered.

Can prostatitis raise PSA enough to look like cancer?

Yes. Inflammation or infection of the prostate can raise PSA sharply, sometimes to levels that would otherwise prompt a biopsy. This is why urologists ask about recent urinary symptoms, fever or infections before interpreting a result, and why a raised PSA during an infection is usually treated and retested rather than acted on immediately. The level typically falls once the inflammation settles.

Does having an enlarged prostate increase my risk of prostate cancer?

No. According to the NHS, benign prostatic hyperplasia does not increase the risk of prostate cancer and does not turn into it. The two conditions arise in different zones of the gland through different processes. A man can have both at the same time, which is why testing continues even when enlargement clearly explains the urinary symptoms.

How long does a prostate biopsy take, and what happens afterward?

The procedure usually takes 10 to 20 minutes under local or general anesthesia, according to the NHS, and is done through the rectum or the skin of the perineum. Blood in the urine or semen for a few weeks and some soreness are common. Infection is the main serious risk. Results include a grade, such as a Gleason score, which guides the discussion about surveillance or treatment.

Is active surveillance a safe way to manage prostate cancer?

For many low-grade cancers, active surveillance is a recognized standard option in NHS and other mainstream guidance. It involves regular PSA tests, exams and MRI scans, with treatment offered if the cancer shows signs of progressing. It aims to avoid or delay side effects of treatment for cancers that may never cause harm. Whether it suits an individual depends on grade, PSA, MRI findings and overall health.

References

• NIDDK (NIH): Prostate Enlargement (Benign Prostatic Hyperplasia)
• NIDDK (NIH): Prostatitis: Inflammation of the Prostate
• NHS: Benign prostate enlargement
• NHS: Prostate cancer

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.